OKLAHOMA CITY, OK — (Marketwire) — 03/22/12 — Graymark Healthcare, Inc. (NASDAQ: GRMH), the nation-s second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), will hold a conference call on Thursday, March 29, 2012 at 4:30 p.m. Eastern time to discuss its financial results for the year ended December 31, 2011. The financial results are expected to be reported in a press release prior to the call.
Graymark-s CEO Stanton Nelson and CFO Ed Carriero will host the conference call, followed by a question and answer period.
Date: Thursday, March 29, 2012
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-888-846-5003
International: 1-480-629-9856
Conference ID#: 4526724
The conference call will be broadcast live at and available for replay via the Investors section of the company-s website at .
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.
A replay of the call will be available after 7:30 p.m. Eastern time on the same day and until April 29, 2012.
Toll-free replay number: 1-877-870-5176
International replay number: 1-858-384-5517
Replay pin number: 4526724
Headquartered in Oklahoma City, Okla., Graymark Healthcare, Inc. (NASDAQ: GRMH) is the nation-s second largest provider of sleep management solutions. In addition to diagnosing and treating over 80 sleep disorders, the company specializes in comprehensive care for Obstructive Sleep Apnea (OSA). Graymark offers its services through 101 sleep laboratories primarily in the Midwest, including standalone or IDTF facilities, therapy facilities, rural outreach hospital sites and urban hospital management agreements. For more information, visit .
This press release contains forward-looking statements that are based on the Company-s current expectations, forecasts and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the Company-s expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not in the control of the Company, including, without limitation, the risk that the transaction does not close as planned or at all, the current economic climate and other risks and uncertainties, including those enumerated and described in the Company-s filings with the Securities and Exchange Commission, which filings are available on the SEC-s website at . Unless otherwise required by law, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Graymark Healthcare, Inc.
Stanton Nelson
Chairman and CEO
Tel 405-601-5300
Liolios Group, Inc.
Scott Liolios or Cody Slach
Tel 949-574-3860